Loading…
Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum
We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites, M‐III and M‐IV, of TAK‐778, which is a new bone anabolic agent, in human serum using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Prior to setting up the an...
Saved in:
Published in: | Journal of mass spectrometry. 2002-06, Vol.37 (6), p.631-638 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003 |
---|---|
cites | cdi_FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003 |
container_end_page | 638 |
container_issue | 6 |
container_start_page | 631 |
container_title | Journal of mass spectrometry. |
container_volume | 37 |
creator | Teshima, Koichiro Kondo, Takahiro Maeda, Chie Oda, Tsuneo Hagimoto, Toshiaki Tsukuda, Ryoichi Yoshimura, Yoshinobu |
description | We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites, M‐III and M‐IV, of TAK‐778, which is a new bone anabolic agent, in human serum using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Prior to setting up the analytical method, we found that 1‐alkylamines co‐existing with M‐III and M‐IV in the turbo ionsprayed solution formed 1‐alkylammonium adduct molecules of these metabolites during the ionization process, and the abundance of the adduct ions was considerably higher than that of protonated molecules ([M + H]+s) of these metabolites. Based on these findings, we investigated a variety of 1‐alkylamines and their spiked concentrations in the mobile phase for LC/MS/MS analysis to obtain higher sensitivities for the quantification of these metabolites. After these examinations, we found that 1‐hexylamine at a final concentration of 0.05 mmol l−1 was the most suitable additive for the mobile phase, and set the selected reaction monitoring (SRM) ions for the 1‐hexylammonium adduct molecule and [M + H]+, allowing about a fivefold gain in the SRM chromatographic peak compared with that without 1‐hexylamine. The adduct ion was considered to be formed by interaction between the amino group of 1‐hexylamine and the phosphoryl group of M‐III and M‐IV. The internal standard (I.S.) used was deuterated M‐III for each metabolite. The analytes and I.S. were extracted with diethyl ether from serum samples at neutral pH and injected into the LC/MS/MS system with a turbo ionspray interface. The limit of quantification for both analytes was 0.5 ng ml−1 when 0.1 ml of serum was used, and the calibration curves were linear in the range 0.5–100 ng ml−1. The method was precise; the intra‐ and inter‐day precisions of the method were not more than 5.6%. The accuracy of the method was good, with deviations between added and calculated concentrations of M‐III and M‐IV being typically within 16.6%. This method provided reliable pharmacokinetic data for M‐III and M‐IV after the intramuscular administration of TAK‐778 sustained‐release formulation in humans. Copyright © 2002 John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/jms.324 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71903284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71903284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003</originalsourceid><addsrcrecordid>eNp10c1u1DAUBeAIgWgpiDdAdwMs2rR24rGT5aii5aeA0FQqYmPdOM6M28TO2I7aeTWeDg8zoitW17I_37M4WfaaklNKSHF2O4TTsmBPskNKap7XVVU93Z4Fz2dUsIPsRQi3hJC6Zvx5dkALSgvB-GH2ez6OvVEYjbPgOqA59nebHgdjdYDoAKE368m0oFbeDRjd0uO4MuosTr5xkL6F0eMGItpWDzBgCBBGrWLSOnqjII2Va6FzHtYT2mi6jbHL7TU2rjcx5aRgBKvvoXFWA9q_DwpwqW08gev5l1yI6gSMhdU0oIWg_TS8zJ512Af9aj-PssXFh-vzj_nV98tP5_OrXDEmWM65anXV1M1MoaZatAqxrDlT2NA2jaoSDdGcVKokVHQzRkvOC1bphiAh5VH2brd19G496RDlYILSfY9WuylIQWtSFhVL8P0OKu9C8LqTozcD-o2kRG5LkqkkmUpK8s1-5dQMun10-1YSeLsHGBT2nUerTHh0pShqXovkjnfu3vR68788-fnrYheb77QJUT_80-jvJBelmMmbb5eyWNxc0J_ih_xV_gFSUrp7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71903284</pqid></control><display><type>article</type><title>Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Teshima, Koichiro ; Kondo, Takahiro ; Maeda, Chie ; Oda, Tsuneo ; Hagimoto, Toshiaki ; Tsukuda, Ryoichi ; Yoshimura, Yoshinobu</creator><creatorcontrib>Teshima, Koichiro ; Kondo, Takahiro ; Maeda, Chie ; Oda, Tsuneo ; Hagimoto, Toshiaki ; Tsukuda, Ryoichi ; Yoshimura, Yoshinobu</creatorcontrib><description>We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites, M‐III and M‐IV, of TAK‐778, which is a new bone anabolic agent, in human serum using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Prior to setting up the analytical method, we found that 1‐alkylamines co‐existing with M‐III and M‐IV in the turbo ionsprayed solution formed 1‐alkylammonium adduct molecules of these metabolites during the ionization process, and the abundance of the adduct ions was considerably higher than that of protonated molecules ([M + H]+s) of these metabolites. Based on these findings, we investigated a variety of 1‐alkylamines and their spiked concentrations in the mobile phase for LC/MS/MS analysis to obtain higher sensitivities for the quantification of these metabolites. After these examinations, we found that 1‐hexylamine at a final concentration of 0.05 mmol l−1 was the most suitable additive for the mobile phase, and set the selected reaction monitoring (SRM) ions for the 1‐hexylammonium adduct molecule and [M + H]+, allowing about a fivefold gain in the SRM chromatographic peak compared with that without 1‐hexylamine. The adduct ion was considered to be formed by interaction between the amino group of 1‐hexylamine and the phosphoryl group of M‐III and M‐IV. The internal standard (I.S.) used was deuterated M‐III for each metabolite. The analytes and I.S. were extracted with diethyl ether from serum samples at neutral pH and injected into the LC/MS/MS system with a turbo ionspray interface. The limit of quantification for both analytes was 0.5 ng ml−1 when 0.1 ml of serum was used, and the calibration curves were linear in the range 0.5–100 ng ml−1. The method was precise; the intra‐ and inter‐day precisions of the method were not more than 5.6%. The accuracy of the method was good, with deviations between added and calculated concentrations of M‐III and M‐IV being typically within 16.6%. This method provided reliable pharmacokinetic data for M‐III and M‐IV after the intramuscular administration of TAK‐778 sustained‐release formulation in humans. Copyright © 2002 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1076-5174</identifier><identifier>EISSN: 1096-9888</identifier><identifier>DOI: 10.1002/jms.324</identifier><identifier>PMID: 12112746</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>1-alkylamines ; adduct ion ; Alkylation ; Amines - chemistry ; Analysis ; Benzothiepins - administration & dosage ; Benzothiepins - blood ; Benzothiepins - pharmacokinetics ; Biological and medical sciences ; Biotransformation ; Blood Chemical Analysis - instrumentation ; Blood Chemical Analysis - methods ; Calibration ; Chromatography, High Pressure Liquid - methods ; General pharmacology ; Humans ; Hydrogen-Ion Concentration ; Injections, Intramuscular ; liquid chromatography/turbo ionspray tandem mass spectrometry ; Mass Spectrometry - methods ; Medical sciences ; metabolite ; Pharmacology. Drug treatments ; quantification ; Reference Standards ; Sensitivity and Specificity ; TAK-778</subject><ispartof>Journal of mass spectrometry., 2002-06, Vol.37 (6), p.631-638</ispartof><rights>Copyright © 2002 John Wiley & Sons, Ltd.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003</citedby><cites>FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13729697$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12112746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teshima, Koichiro</creatorcontrib><creatorcontrib>Kondo, Takahiro</creatorcontrib><creatorcontrib>Maeda, Chie</creatorcontrib><creatorcontrib>Oda, Tsuneo</creatorcontrib><creatorcontrib>Hagimoto, Toshiaki</creatorcontrib><creatorcontrib>Tsukuda, Ryoichi</creatorcontrib><creatorcontrib>Yoshimura, Yoshinobu</creatorcontrib><title>Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum</title><title>Journal of mass spectrometry.</title><addtitle>J. Mass Spectrom</addtitle><description>We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites, M‐III and M‐IV, of TAK‐778, which is a new bone anabolic agent, in human serum using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Prior to setting up the analytical method, we found that 1‐alkylamines co‐existing with M‐III and M‐IV in the turbo ionsprayed solution formed 1‐alkylammonium adduct molecules of these metabolites during the ionization process, and the abundance of the adduct ions was considerably higher than that of protonated molecules ([M + H]+s) of these metabolites. Based on these findings, we investigated a variety of 1‐alkylamines and their spiked concentrations in the mobile phase for LC/MS/MS analysis to obtain higher sensitivities for the quantification of these metabolites. After these examinations, we found that 1‐hexylamine at a final concentration of 0.05 mmol l−1 was the most suitable additive for the mobile phase, and set the selected reaction monitoring (SRM) ions for the 1‐hexylammonium adduct molecule and [M + H]+, allowing about a fivefold gain in the SRM chromatographic peak compared with that without 1‐hexylamine. The adduct ion was considered to be formed by interaction between the amino group of 1‐hexylamine and the phosphoryl group of M‐III and M‐IV. The internal standard (I.S.) used was deuterated M‐III for each metabolite. The analytes and I.S. were extracted with diethyl ether from serum samples at neutral pH and injected into the LC/MS/MS system with a turbo ionspray interface. The limit of quantification for both analytes was 0.5 ng ml−1 when 0.1 ml of serum was used, and the calibration curves were linear in the range 0.5–100 ng ml−1. The method was precise; the intra‐ and inter‐day precisions of the method were not more than 5.6%. The accuracy of the method was good, with deviations between added and calculated concentrations of M‐III and M‐IV being typically within 16.6%. This method provided reliable pharmacokinetic data for M‐III and M‐IV after the intramuscular administration of TAK‐778 sustained‐release formulation in humans. Copyright © 2002 John Wiley & Sons, Ltd.</description><subject>1-alkylamines</subject><subject>adduct ion</subject><subject>Alkylation</subject><subject>Amines - chemistry</subject><subject>Analysis</subject><subject>Benzothiepins - administration & dosage</subject><subject>Benzothiepins - blood</subject><subject>Benzothiepins - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Biotransformation</subject><subject>Blood Chemical Analysis - instrumentation</subject><subject>Blood Chemical Analysis - methods</subject><subject>Calibration</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Injections, Intramuscular</subject><subject>liquid chromatography/turbo ionspray tandem mass spectrometry</subject><subject>Mass Spectrometry - methods</subject><subject>Medical sciences</subject><subject>metabolite</subject><subject>Pharmacology. Drug treatments</subject><subject>quantification</subject><subject>Reference Standards</subject><subject>Sensitivity and Specificity</subject><subject>TAK-778</subject><issn>1076-5174</issn><issn>1096-9888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp10c1u1DAUBeAIgWgpiDdAdwMs2rR24rGT5aii5aeA0FQqYmPdOM6M28TO2I7aeTWeDg8zoitW17I_37M4WfaaklNKSHF2O4TTsmBPskNKap7XVVU93Z4Fz2dUsIPsRQi3hJC6Zvx5dkALSgvB-GH2ez6OvVEYjbPgOqA59nebHgdjdYDoAKE368m0oFbeDRjd0uO4MuosTr5xkL6F0eMGItpWDzBgCBBGrWLSOnqjII2Va6FzHtYT2mi6jbHL7TU2rjcx5aRgBKvvoXFWA9q_DwpwqW08gev5l1yI6gSMhdU0oIWg_TS8zJ512Af9aj-PssXFh-vzj_nV98tP5_OrXDEmWM65anXV1M1MoaZatAqxrDlT2NA2jaoSDdGcVKokVHQzRkvOC1bphiAh5VH2brd19G496RDlYILSfY9WuylIQWtSFhVL8P0OKu9C8LqTozcD-o2kRG5LkqkkmUpK8s1-5dQMun10-1YSeLsHGBT2nUerTHh0pShqXovkjnfu3vR68788-fnrYheb77QJUT_80-jvJBelmMmbb5eyWNxc0J_ih_xV_gFSUrp7</recordid><startdate>200206</startdate><enddate>200206</enddate><creator>Teshima, Koichiro</creator><creator>Kondo, Takahiro</creator><creator>Maeda, Chie</creator><creator>Oda, Tsuneo</creator><creator>Hagimoto, Toshiaki</creator><creator>Tsukuda, Ryoichi</creator><creator>Yoshimura, Yoshinobu</creator><general>John Wiley & Sons, Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200206</creationdate><title>Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum</title><author>Teshima, Koichiro ; Kondo, Takahiro ; Maeda, Chie ; Oda, Tsuneo ; Hagimoto, Toshiaki ; Tsukuda, Ryoichi ; Yoshimura, Yoshinobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>1-alkylamines</topic><topic>adduct ion</topic><topic>Alkylation</topic><topic>Amines - chemistry</topic><topic>Analysis</topic><topic>Benzothiepins - administration & dosage</topic><topic>Benzothiepins - blood</topic><topic>Benzothiepins - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Biotransformation</topic><topic>Blood Chemical Analysis - instrumentation</topic><topic>Blood Chemical Analysis - methods</topic><topic>Calibration</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Injections, Intramuscular</topic><topic>liquid chromatography/turbo ionspray tandem mass spectrometry</topic><topic>Mass Spectrometry - methods</topic><topic>Medical sciences</topic><topic>metabolite</topic><topic>Pharmacology. Drug treatments</topic><topic>quantification</topic><topic>Reference Standards</topic><topic>Sensitivity and Specificity</topic><topic>TAK-778</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teshima, Koichiro</creatorcontrib><creatorcontrib>Kondo, Takahiro</creatorcontrib><creatorcontrib>Maeda, Chie</creatorcontrib><creatorcontrib>Oda, Tsuneo</creatorcontrib><creatorcontrib>Hagimoto, Toshiaki</creatorcontrib><creatorcontrib>Tsukuda, Ryoichi</creatorcontrib><creatorcontrib>Yoshimura, Yoshinobu</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of mass spectrometry.</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teshima, Koichiro</au><au>Kondo, Takahiro</au><au>Maeda, Chie</au><au>Oda, Tsuneo</au><au>Hagimoto, Toshiaki</au><au>Tsukuda, Ryoichi</au><au>Yoshimura, Yoshinobu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum</atitle><jtitle>Journal of mass spectrometry.</jtitle><addtitle>J. Mass Spectrom</addtitle><date>2002-06</date><risdate>2002</risdate><volume>37</volume><issue>6</issue><spage>631</spage><epage>638</epage><pages>631-638</pages><issn>1076-5174</issn><eissn>1096-9888</eissn><abstract>We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites, M‐III and M‐IV, of TAK‐778, which is a new bone anabolic agent, in human serum using liquid chromatography/tandem mass spectrometry (LC/MS/MS). Prior to setting up the analytical method, we found that 1‐alkylamines co‐existing with M‐III and M‐IV in the turbo ionsprayed solution formed 1‐alkylammonium adduct molecules of these metabolites during the ionization process, and the abundance of the adduct ions was considerably higher than that of protonated molecules ([M + H]+s) of these metabolites. Based on these findings, we investigated a variety of 1‐alkylamines and their spiked concentrations in the mobile phase for LC/MS/MS analysis to obtain higher sensitivities for the quantification of these metabolites. After these examinations, we found that 1‐hexylamine at a final concentration of 0.05 mmol l−1 was the most suitable additive for the mobile phase, and set the selected reaction monitoring (SRM) ions for the 1‐hexylammonium adduct molecule and [M + H]+, allowing about a fivefold gain in the SRM chromatographic peak compared with that without 1‐hexylamine. The adduct ion was considered to be formed by interaction between the amino group of 1‐hexylamine and the phosphoryl group of M‐III and M‐IV. The internal standard (I.S.) used was deuterated M‐III for each metabolite. The analytes and I.S. were extracted with diethyl ether from serum samples at neutral pH and injected into the LC/MS/MS system with a turbo ionspray interface. The limit of quantification for both analytes was 0.5 ng ml−1 when 0.1 ml of serum was used, and the calibration curves were linear in the range 0.5–100 ng ml−1. The method was precise; the intra‐ and inter‐day precisions of the method were not more than 5.6%. The accuracy of the method was good, with deviations between added and calculated concentrations of M‐III and M‐IV being typically within 16.6%. This method provided reliable pharmacokinetic data for M‐III and M‐IV after the intramuscular administration of TAK‐778 sustained‐release formulation in humans. Copyright © 2002 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>12112746</pmid><doi>10.1002/jms.324</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1076-5174 |
ispartof | Journal of mass spectrometry., 2002-06, Vol.37 (6), p.631-638 |
issn | 1076-5174 1096-9888 |
language | eng |
recordid | cdi_proquest_miscellaneous_71903284 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | 1-alkylamines adduct ion Alkylation Amines - chemistry Analysis Benzothiepins - administration & dosage Benzothiepins - blood Benzothiepins - pharmacokinetics Biological and medical sciences Biotransformation Blood Chemical Analysis - instrumentation Blood Chemical Analysis - methods Calibration Chromatography, High Pressure Liquid - methods General pharmacology Humans Hydrogen-Ion Concentration Injections, Intramuscular liquid chromatography/turbo ionspray tandem mass spectrometry Mass Spectrometry - methods Medical sciences metabolite Pharmacology. Drug treatments quantification Reference Standards Sensitivity and Specificity TAK-778 |
title | Application of 1-alkylamines to a liquid chromatographic/turbo ionspray tandem mass spectrometric method for quantifying metabolites of a new bone anabolic agent, TAK-778, in human serum |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%201-alkylamines%20to%20a%20liquid%20chromatographic/turbo%20ionspray%20tandem%20mass%20spectrometric%20method%20for%20quantifying%20metabolites%20of%20a%20new%20bone%20anabolic%20agent,%20TAK-778,%20in%20human%20serum&rft.jtitle=Journal%20of%20mass%20spectrometry.&rft.au=Teshima,%20Koichiro&rft.date=2002-06&rft.volume=37&rft.issue=6&rft.spage=631&rft.epage=638&rft.pages=631-638&rft.issn=1076-5174&rft.eissn=1096-9888&rft_id=info:doi/10.1002/jms.324&rft_dat=%3Cproquest_cross%3E71903284%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4474-66cde8b9b5cae1e7dcaa3964cab1d64c887b0e608c3017f541366248eb0a003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71903284&rft_id=info:pmid/12112746&rfr_iscdi=true |